348
Views
8
CrossRef citations to date
0
Altmetric
Review

Edoxaban for the prevention of stroke in patients with atrial fibrillation

, &
Pages 319-330 | Received 04 Jan 2019, Accepted 19 Mar 2019, Published online: 27 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tarek Ajam, Tabitha L Cumpian, Blair L Tilkens, Imaan A Jahangir, Jared Frost, Cheryl Ceretto & Arshad Jahangir. (2020) Non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly. Expert Review of Clinical Pharmacology 13:12, pages 1309-1327.
Read now

Articles from other publishers (7)

Bailin Zhang, Winglam Cheng, Wulamiding Kaisaier, Zhenbang Gu, Wengen Zhu & Qiuhua Jiang. (2023) Effect of edoxaban compared with other oral anticoagulants for stroke prevention in patients with atrial fibrillation: A meta-analysis. Heliyon 9:11, pages e21740.
Crossref
Bryan Beleño Acosta, Rigoberto C. Advincula & Carlos David Grande-Tovar. (2023) Chitosan-Based Scaffolds for the Treatment of Myocardial Infarction: A Systematic Review. Molecules 28:4, pages 1920.
Crossref
Gonzalo Barón-Esquivias, Inmaculada Roldán Rabadán, Antonio García Quintana, Juan José Cerezo Manchado, M. Isabel Antorrena Miranda, José Javier Gómez-Barrado, Matías Pérez Paredes, Enrique Santas, Javier Pindado Rodríguez, Jorge Andrés Muñoz-Robles, Desamparados Oliver-Miñarro & María Amparo Santamaría Ortiz. (2022) Seguridad y efectividad del edoxabán en la práctica clínica tras un año de seguimiento en España. Registro ETNA-AF-EUROPE. REC: CardioClinics 57:1, pages 39-47.
Crossref
Andrew Willeford, Wenhong Zhu, Craig Stevens & Isac C. Thomas. (2020) Direct Oral Anticoagulants Versus Warfarin in the Treatment of Left Ventricular Thrombus. Annals of Pharmacotherapy 55:7, pages 839-845.
Crossref
Leif E. Peterson. (2021) In Silico Molecular Dynamics Docking of Drugs to the Inhibitory Active Site of SARS-CoV-2 Protease and Their Predicted Toxicology and ADME. African Journal of Pharmaceutical Sciences 1:2, pages 16.
Crossref
Gianluca Grimaldi, Domenica Ancona, Domenico Tricarico, Paolo Stella, Cataldo Procacci, Antonio Germinario, Vito Bavaro, Vito Montanaro & Alessandro Delle Donne. (2021) Analysis of the Introduction in Clinical Practice of New Oral Anticoagulants in Local Health Agency BT: Translation of the Clinical Trial Data to a Local Health Care Area. Pharmaceutics 13:2, pages 252.
Crossref
Ísis Venturi Biembengut & Tatiana de Arruda Campos Brasil de Souza. (2020) Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach. Memórias do Instituto Oswaldo Cruz 115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.